פרגוליד טבע ® 0.25 מ"ג
Country: Iżrael
Lingwa: Ebrajk
Sors: Ministry of Health
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Ingredjent attiv:
PERGOLIDE AS MESYLATE 0.25 MG
Disponibbli minn:
TEVA PHARMACEUTICAL INDUST.LTD
Kodiċi ATC:
N04BC02
Għamla farmaċewtika:
TABLETS
Rotta amministrattiva:
PER OS
Manifatturat minn:
TEVA PHARMACEUTICAL INDUSTRIES LTD
Grupp terapewtiku:
PERGOLIDE
Indikazzjonijiet terapewtiċi:
Pergolide is indicated as adjunctive treatment to levodopa/carbidopa in the management of the signs and symptoms of Parkinson's disease with on-off phenomena. Pergolide is indicated as monotherapy in the initial treatment period of Parkinson's disease.
Data ta 'l-awtorizzazzjoni:
2009-02-01
